Skip to content
healthcare.dev

TORPENZ

NDC 0245-0823, Everolimus, tablet, from Upsher-Smith Laboratories, LLC.

Product NDC
0245-0823
Status
Listed
Labeler
Upsher-Smith Laboratories, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214182
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0245-0823 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS5 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
0245-0823-040024508230428 BLISTER PACK in 1 CARTON (0245-0823-04) / 1 TABLET in 1 BLISTER PACK (0245-0823-89)
0245-0823-300024508233030 TABLET in 1 BOTTLE (0245-0823-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4c0075dd-a0a8-4dc4-be32-1be8383fbbdc
  • NADAC price for package 00245082304

    GET /v1/drugs/nadac/00245082304
  • NADAC price for package 00245082330

    GET /v1/drugs/nadac/00245082330

Use it

Look up 0245-0823 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0245-0823 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0245-0823. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.